GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Simcere Pharmaceutical Group Ltd (HKSE:02096) » Definitions » 5-Year Yield-on-Cost %

Simcere Pharmaceutical Group (HKSE:02096) 5-Year Yield-on-Cost % : 2.83 (As of Sep. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Simcere Pharmaceutical Group 5-Year Yield-on-Cost %?

Simcere Pharmaceutical Group's yield on cost for the quarter that ended in Dec. 2023 was 2.83.


The historical rank and industry rank for Simcere Pharmaceutical Group's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:02096' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.23   Med: 2.28   Max: 3.47
Current: 2.83


During the past 7 years, Simcere Pharmaceutical Group's highest Yield on Cost was 3.47. The lowest was 1.23. And the median was 2.28.


HKSE:02096's 5-Year Yield-on-Cost % is ranked better than
59.14% of 509 companies
in the Drug Manufacturers industry
Industry Median: 2.19 vs HKSE:02096: 2.83

Competitive Comparison of Simcere Pharmaceutical Group's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simcere Pharmaceutical Group's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Simcere Pharmaceutical Group's 5-Year Yield-on-Cost % falls into.



Simcere Pharmaceutical Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Simcere Pharmaceutical Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Simcere Pharmaceutical Group  (HKSE:02096) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Simcere Pharmaceutical Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Simcere Pharmaceutical Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Simcere Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu, Nanjing, CHN, 210042
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
Executives
Wang Xi 2305 Beneficiary of a trust
Ren Jinsheng 2202 Interest of your spouse
Right Wealth Holdings Limited 2501 Other
Wang Xi 2501 Other
Simcere Investments Group Limited 2501 Other
Excel Investments Group Limited 2501 Other
Simcere Pharmaceutical Holding Limited 2501 Other
Simcere Holding Limited 2501 Other
Artking Global Limited 2501 Other
Ren Zhen 2501 Other
Ren Yong 2501 Other
Ren Weidong 2501 Other
Peng Suqin 2501 Other
P&h Holdings Group Ltd. 2501 Other
Li Shimeng 2501 Other

Simcere Pharmaceutical Group Headlines

No Headlines